Mobile cardiac telemetry and near-real-time analytics offer clinical value that remains underused. But recommending real time analysis for every patient produces alert fatigue, unnecessary cost, and noise that erodes clinician trust, while defaulting to retrospective analysis risks missing the signals that demand same-day action. This session asks where real-time monitoring meaningfully changes care, where Holter and extended Holter studies remain the better choice, and what medical-grade analytics, and notification configurations must deliver to make real-time something clinicians can trust and act on. This roundtable reframes real-time versus retrospective monitoring from a winner-take-all debate into a more useful question: which approach fits which clinical scenario. Bringing electrophysiologists, general cardiologists, and technologists together, we will map where true near-real-time mobile cardiac telemetry delivers value that Holter and extended-Holter studies cannot, and where the established approaches remain appropriate. We will then confront the requirement that determines whether MCT’s promise is realized in practice: medical-grade, validated analytics that deliver accuracy and actionable insight at scale, and workflow practices that keep alert fatigue from undermining adoption.
Powered by AccurKardia
